News

In this section you will find the most recent news articles of interest to both patients and healthcare professionals.

Venous thromboembolism CMO press release

Every hospital patient should have their own risk assessment for VTE that will improve patient safety and help save thousands of lives each year, says an expert working group whose report was launched by the Chief Medical Officer (CMO) today.

Read more »

NICE guidance on Venous Thromboembolism (VTE)

NICE has now issued its guidance on the prevention of venous thromboembolism for surgical patients.

Read more »

European Medicines Agency recommends approval of dabigatran etexilate

European Medicines Agency recommends approval of novel oral anticoagulant, dabigatran etexilate (Pradaxa®)

Read more »

The National Patient Safety Agency Needs Your Help

The National Patient Safety Agency (NPSA) issued a patient safety alert for anticoagulation therapy and also new guidance about how some of the systems should work.

Read more »

Einstein - Extension study

Results from the EINSTEIN-Extension study, demonstrate that the factor Xa inhibitor rivaroxaban (Xarelto), when compared to placebo, significantly reduced the risk of a recurrent symptomatic venous thromboembolism (VTE).

Read more »

RE-COVER Study

New anticoagulant drug dabigatran is a safe effective alternative to warfarin for the treatment of Venous thromboembolism Venous thromboembolism is the umbrella term for deep vein thrombosis (blood clots in the legs and pulmonary embolism (blood clots in the lungs.

Read more »

New anticoagulants - latest news

In September 2010 the U.S. Food and Drugs Administration (FDA) Advisory Committee has recommended dabigatran etexilate (Pradaxa) for use in stroke prevention for patients with non-valvular atrial fibrillation (AF).

Read more »

It's About Time Campaign (2004)

A campaign to increase understanding of thrombosis and stroke prevention

Read more »

1 Mission 1 Million - Getting to the Heart of Stroke

1 Mission 1 Million – Getting to the Heart of Stroke.

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space